Quality of life of patients with systemic mast cell disease before and under basic therapy
- Conditions
- D47.0Histiocytic and mast cell tumours of uncertain and unknown behaviour
- Registration Number
- DRKS00015691
- Lead Sponsor
- niversitätsklinikum Bonn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Presence of mast cell disease (SM / MCAD); Participants are part of the basic therapy (H1- / H2-blockers, mast cell stabilizers); no chronic previous illness in the comparison group
Exclusion Criteria
Inability to give informed and written consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of quality of life of healthy and sick patients;<br><br>Change in quality of life during therapy: using the QLQ-C30 questionnaire;<br><br>Information obtained from treating physicians regarding illness: based on QLQ Info25 questionnaire
- Secondary Outcome Measures
Name Time Method Differences in mast cell medication and their effects on quality of life: using the QLQ-C30 questionnaire